| 31618-90-3 |
Diethyl(tosyloxy)methylphosphonate |
Anti-virals |
Adefovir dipivoxil Intermediates |
CAS NO:31618-90-3
Molecular formula:C12H19O6PS
Molecular weight:322.31 |
Appearance:light yellow or colorless transparent oilly liquid Assay:90%min |
| 707-99-3 |
2-(6-Aminopurin-9-yl)ethanol |
Anti-virals |
Adefovir dipivoxil Intermediates |
CAS NO: 707-99-3
Molecular formula: C7H9N5O
Molecular weight: 179.18 |
Appearance:white powder Assay:99%min |
| 116384-53-3 |
[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid diethyl ester |
Anti-virals |
Adefovir dipivoxil Intermediates |
CAS NO: 116384-53-3
Molecular formula: C12H20N5O4P
Molecular weight: 329.29 |
Appearance:pale yellow to white powderPurity:≥99.0% |
| 106941-25-7 |
9-[2-Phosphonylmethoxyethyl]adenine |
Anti-virals |
Adefovir dipivoxil Intermediates |
CAS NO: 106941-25-7
Molecular formula: C8H12N5O4P
Molecular weight: 273.19 |
Appearance: White to Light Brown Solid
Melting Point: >282°C (dec.) Purity:≥99.0% |
| 206184-49-8 |
[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic acid monohydrate |
Anti-virals |
Tenofovir disoproxil fumarate Intermediates |
CAS NO: 206184-49-8
Molecular formula: C9H14N5O4P.H2O
Molecular weight: 305.23 |
Appearance: White appearance
Melting Point: 270-274ºC Purity:≥99.0% |
| 31618-90-3 |
Diethyl(tosyloxy)methylphosphonate |
Anti-virals |
Tenofovir disoproxil fumarate Intermediates |
CAS NO: 31618-90-3
Molecular formula: C12H19O6PS
Molecular weight: 322.3 |
Appearance: white powder
Purity:≥99.0% |
| 14047-28-0 |
(R)-(+)-9-(2-Hydroxypropyl)adenine |
Anti-virals |
Tenofovir disoproxil fumarate Intermediates |
CAS NO: 14047-28-0
Molecular formula: C8H11N5O
Molecular weight: 193.21 |
Appearance: White powder
Melting Point: 270-274ºC Purity:≥99.0% |
| 142217-78-5 |
(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol |
Anti-virals |
Entecavir hydrate Intermediates |
CAS NO: 142217-78-5
Molecular formula: C52H49N5O5
Molecular weight: 823.98
Standard: Enterprise standard
Application: Entecavir intermediates |
Appearance:Light yellow to off-white powder
Identification:IR/HPLC
Water:≤1.0%
Chiral purity:≥97.0%
Purity:≥98.0% |
| 142217-80-9 |
6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine |
Anti-virals |
Entecavir hydrate Intermediates |
CAS NO: 142217-80-9
Molecular formula: C53H49N5O4
Molecular weight: 819.99 |
Appearance:Light yellow to off-white powder
Identification:IR/HPLC
Purity:≥99.0%
|
| 142217-81-0 |
2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
Anti-virals |
Entecavir hydrate Intermediates |
CAS NO: 142217-81-0
Molecular formula: C26H27N5O3
Molecular weight: 457.52
Standard: Enterprise standard
Application: Entecavir Intermediate |
Appearance:Light yellow to off-white powder
Identification:IR/HPLC
Purity:≥98.0% |
| 161797-99-5 |
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate |
Antigout |
Febuxostat Intermediates |
CAS NO: 161797-99-5
Molecular formula: C13H13NO3S
Molecular weight: 263.31
Application: Febuxostat Intermediates |
Appearance:Light yellow to off-white powder
Identification:IR/HPLC
Purity:≥98.0% |
| 161798-01-2 |
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate |
Antigout |
Febuxostat Intermediates |
CAS NO: 161798-01-2
Molecular formula: C14H13NO4S
Molecular weight: 291.32
Application: Febuxostat Intermediates |
Appearance:Yellow crystalline powder
Identification:IR/HPLC
Purity:≥98.0% |
| 161798-02-3 |
Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate |
Antigout |
Febuxostat Intermediates |
CAS NO: 161798-02-3
Molecular formula: C14H12N2O3S
Molecular weight: 288.32
Application: Febuxostat Intermediates |
Appearance:off-white crystalline powder
Identification:IR/HPLC
Purity:≥98.0% |
| 161798-03-4 |
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate |
Antigout |
Febuxostat Intermediates |
CAS NO: 161798-03-4
Molecular formula: C18H21NO4S
Molecular weight: 347.43
Application: Febuxostat Intermediates |
Appearance:Yellow crystalline powder
Identification:IR/HPLC
Purity:≥97.0% |
| 160844-75-7 |
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate |
Antigout |
Febuxostat Intermediates |
CAS NO: 160844-75-7
Molecular formula: C18H20N2O3S
Molecular weight: 344.43
Application: Febuxostat Intermediates |
Appearance:White to off-white crystalline powder
Identification:IR/HPLC
Purity:≥98.0% |
| 290297-25-5 |
N-Methyl-4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinamine |
Anti-nausea |
Netupitant Intermediates |
CAS NO: 290297-25-5
Molecular formula: C18H24N4
Molecular weight: 296.41 |
Appearance: white powder
Purity:≥99.0% |
| 289686-70-0 |
2-(3,5-Bis(trifluoromethyl)phenyl)-2-methylpropionic acid |
Anti-nausea |
Netupitant Intermediates |
CAS NO: 289686-70-0
Molecular formula: C12H10F6O2
Molecular weight: 300.20
Standard: 98.0%min |
Appearance:White to off-white crystalline powder
Identification:IR/HPLC
Purity:≥98.0% |
| 931-86-2 |
5-Azacytosine |
Anti-Oncology |
Decitabine Intermediates |
CAS NO: 931-86-2
Molecular formula: C3H4N4O
Molecular weight: 112.09
Standard: Enterprise standard
Application: Decitabine intermediates |
Appearance:White to off white crystalline powder
Identification:IR/HPLC
Melting point:≥300℃
Loss on drying:≤3.0%
Heavy metals:≤10 ppm
Purity(HPLC):≥98.0% |
| 533-67-5 |
2-Deoxy-D-ribose |
Anti-Oncology |
Decitabine Intermediates |
CAS NO: 533-67-5
Molecular formula: C5H10O4
Molecular weight: 134.13
Standard: Enterprise standard
Application: Decitabine intermediates |
Appearance:White to off-white crystalline powder
Identification;HPLC
Special optical rotation:-54.0~-58.0°
Melting point:≥79.0℃
Loss on drying:≤0.5%
Residue on ignition:≤1.0%
Heavy metals:≤20ppm
Purity:≥98.0% |
| 635702-60-2 |
2,3-Dimethyl-2H-indazol-6-amine hydrochloride |
Anti-Oncology |
Pazopanib Intermediates |
CAS NO: 635702-60-2
Molecular formula: C9H11N3.HCl
Molecular weight: 197.67
Standard: Enterprise standard |
Appearance:off-white or yellow crystalline powder
Identification:HNMR(DMSO)
Waters:≤1.0%
Melting Point:272.0~276.0℃
Purity(HPLC):≥98.0% |
| 3934-20-1 |
2,4-Dichloropyrimidine |
Anti-Oncology |
Pazopanib Intermediates |
CAS NO: 3934-20-1
Molecular formula: C4H2Cl2N2
Molecular weight: 148.98
Standard: 3934-20-1 |
Appearance:Off-white to light yellow crystalline powder
Melting point:57.0~62.0℃
Loss on drying:≤1.0%
Purity(HPLC ):≥98.0% |
| 6973-09-7 |
5-Amino-2-methylbenzenesulfonamide |
Anti-Oncology |
Pazopanib Intermediates |
CAS NO: 6973-09-7
Molecular formula: C7H10N2O2S
Molecular weight: 186.23
Standard: Enterprise standard
Application: pazopanib intermediates |
Appearance:yellow powder
Melting point:166.0~170.0℃
Loss on drying:≤0.5%
Purity(HPLC):≥99.0% |
| 179324-87-9 |
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate |
Anti-Oncology |
Bortezomib Intermediates |
CAS NO: 179324-87-9
Molecular formula: C15H28BNO2.C2HF3O2
Molecular weight: 379.23
Standard: Enterprise standard
Application: Bortezomib Intermediates |
Appearance:White to off-white powder
Identification;H-NRM
Water:≤2.0%
(S)-Isomer:≤1.0%
Assay:97.0%~103.0%（Calculated on anhydrous substance） |
| 205393-22-2 |
Bortezomib-pinanediol |
Anti-Oncology |
Bortezomib Intermediates |
CAS NO: 205393-22-2
Molecular formula: C29H39BN4O4
Molecular weight: 518.46
Application: Bortezomib Intermediates |
Appearance:White to off-white powder
Purity:≥99.0% |
| 3235-69-6 |
Morpholin-4-ylacetic acid |
Anti-Oncology |
Carfilzomib Intermediates |
CAS NO: 3235-69-6
Molecular formula: C6H11NO3
Molecular weight: 145.16 |
Appearance:White powder |
| 868539-99-5 |
(alphaS)-alpha-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine methyl ester mono(trifluoroacetate) |
Anti-Oncology |
Carfilzomib Intermediates |
CAS NO: 868539-99-5
Molecular formula: C26H35N3O4.C2HF3O2
Molecular weight: 567.60 |
Appearance:White powder
Purity:≥99.0% |
| 247068-82-2 |
[(1S)-3-Methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]carbamicacid 1,1-dimethylethyl ester |
Anti-Oncology |
Carfilzomib Intermediates |
CAS NO: 247068-82-2
Molecular formula: C14H25NO4
Molecular weight: 271.35 |
Appearance:White powder
Purity:≥99.0% |
| 247068-85-5 |
(2S)-2-Amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanone trifluoroacetate |
Anti-Oncology |
Carfilzomib Intermediates |
CAS NO: 247068-85-5
Molecular formula: C9H17NO2.C2HF3O2
Molecular weight: 285.26 |
Appearance:white powder
Purity:≥98%
Loss on drying :≤2.0% |
| 622369-40-8 |
4-Chloro-7-fluoro-6-methoxy-3-quinolinecarbonitrile |
Anti-Oncology |
Bosutinib Intermediates |
CAS NO: 622369-40-8
Molecular formula: C11H6ClFN2O
Molecular weight: 236.63
Application: Bosutinib Intermediate |
Appearance:light yellow to off white powder
Purity:98%min
Boiling point:394.76°C at 760 mmHg |
| 290297-25-5 |
N-Methyl-4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinamine |
Anti-nausea |
Netupitant Intermediates |
CAS NO: 290297-25-5
Molecular formula: C18H24N4
Molecular weight: 296.41
Standard: 98.5%MIN |
Appearance: white powder
Purity:≥98.0% |
| 214470-68-5 |
4-Chloro-7-(3-chloropropoxy)-3-cyano-6-methoxyquinoline |
Anti-Oncology |
Bosutinib Intermediates |
CAS NO: 214470-68-5
Molecular formula: C14H12Cl2N2O2
Molecular weight: 311.16
Application: Bosutinib Intermediate |
Appearance:white powder
Purity:≥98%
Loss on drying :≤2.0% |
| 14192-26-8 |
Methyl 2-oxoindole-6-carboxylate |
Anti-Oncology |
Intedanib Intermediates |
CAS NO: 14192-26-8
Molecular formula: C10H9NO3
Molecular weight: 191.18 |
Appearance: white powder
Purity:≥99.0% |
| 262368-30-9 |
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide |
Anti-Oncology |
Intedanib Intermediates |
CAS NO: 262368-30-9
Molecular formula: C14H22N4O
Molecular weight: 262 |
Appearance: white powder
Purity:≥99.0% |
| 666816-98-4 |
8-Bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione |
Anti-diabetic |
Linagliptin Intermediates |
CAS NO: 666816-98-4
Molecular formula: C10H9BrN4O2
Molecular weight: 297.11
Application: Linagliptin Intermediate |
Appearance:White to off-white crystalline powder
Identification:HPLC
Loss on drying:≤0.5%
Residue on ignition:≤0.2%
Heavy metals:≤20ppm
Purity:≥98.0% |
| 109113-72-6 |
2-(Chloromethyl)-4-methylquinazoline |
Anti-diabetic |
Linagliptin Intermediates |
CAS NO: 109113-72-6
Molecular formula: C10H9ClN2
Molecular weight: 192.64
Standard: Enterprsie standard
Application: Linagliptin intermediate |
Appearance:Pale yellow to yellow powder
Identification:HPLC
Water:≤0.5%
Residue on ignition:≤0.2%
Heavy metals:≤20ppm
Purity:≥99.0% |
| 853029-57-9 |
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione |
Anti-diabetic |
Linagliptin Intermediates |
CAS NO: 853029-57-9
Molecular formula: C20H17BrN6O2
Molecular weight: 453.29
Standard: Enterprise standard
Application: Linagliptin intermediates |
Appearance:Off-white powder
Identification:IR/HPLC
Water:≤1.0%
Purity:≥99.0% |
| 309956-78-3 |
(R)-3-(Boc-Amino)piperidine |
Anti-diabetic |
Linagliptin Intermediates |
CAS NO: 309956-78-3
Molecular formula: C10H20N2O2
Molecular weight: 200.28
Standard: Enterprise standard
Application: Linagliptin Intermediate |
Appearance:White crystalline powder
Water:≤0.5%
Chrial purity:≥99.0%
Purity:≥98.00% |
| 865758-96-9 |
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]benzonitrile |
Anti-diabetic |
Alogliptin benzoate Intermediates |
CAS NO: 865758-96-9
Molecular formula: C13H10ClN3O2
Molecular weight: 275.69
Standard: Enterprise standard
Application: Alogliptin Intermediate |
Appearance:White to off-white crystalline powder
Identification:HPLC
Solubility:Soluble in methanol , ethanol, dissolution in ethyl acetate, slightly soluble in water
Heavy metals:≤10ppm
Loss on drying:≤0.5%
Assay:98.0%~102.0%(Calculated on anhydrous substance) |
| 334618-23-4 |
(R)-3-Aminopiperidine dihydrochloride |
Anti-diabetic |
Alogliptin benzoate Intermediates |
CAS NO: 334618-23-4
Molecular formula: C5H14Cl2N2
Molecular weight: 173.08
Standard: Enterprise standard
Application: Alogliptin Intermediates |
Appearance:White to off-white crystalline powder
Identification:HPLC/IR
Chrial purity:≥99.0%
Water:≤0.5%
Assay:98.0%~102.0%(Calculated on anhydrous substance) |
| 361440-67-7 |
(1S,3S,5S)-3-(Aminocarbonyl)-2- azabicyclo[3.1.0 ]hexane-2-carboxylic acid tert-butyl ester |
Anti-diabetic |
Saxagliptin hydrochloride Intermediates |
CAS NO: 361440-67-7
Molecular formula: C11H18N2O3
Molecular weight: 226.27
Application: Saxagliptin intermediate |
Appearance：White to off-white power
Identification：IR/HPLC
Loss on drying：≤1.0%
Chrial purity (ee)：≥99.0%
Asssay (HPLC)：≥98.0% (calculated on anhydrous substance) |
| 361442-00-4 |
Boc-3-Hydroxy-1-adamantyl-D-glycine |
Anti-diabetic |
Saxagliptin hydrochloride Intermediates |
CAS NO: 361442-00-4
Molecular formula: C17H27NO5
Molecular weight: 325.40
Standard: Enterprise standard
Application: Saxagliptin intermediate |
Appearance:White to off-white crystalline power
Identification:IR/HPLC
Residue on ignition≤0.5%
Loss on drying:≤1.0%
Purity:≥98.0%
Chrial purity:≥98.0%
Assay (HPLC):≥98.0% (calculated on anhydrous substance) |
| 461432-23-5 |
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether |
Anti-diabetic |
Dapagliflozin Intermediates |
CAS NO: 461432-23-5
Molecular formula: C15H14BrClO
Molecular weight: 325.63
Standard: Enterprise standard
Application: Dapagliflozin Intermedia |
Description:White powder
Identification:HPLC
Purity(HPLC):≥99.0% |
| 461432-22-4 |
(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone |
Anti-diabetic |
Dapagliflozin Intermediates |
CAS NO: 461432-22-4
Molecular formula: C15H12BrClO2
Molecular weight: 339.61
Standard: Enterprise standard
Application: Dapagliflozin Intermediate |
Appearance:White powder
Identificaiton:HPLC
Purity:≥98.0% |
| 58861-48-6 |
2-(4-fluorophenyl)thiophene |
Anti-diabetic |
Canagliflozin hemihydrate Intermediates |
CAS NO: 58861-48-6
Molecular formula: C10H7FS
Molecular weight: 178.23 |
Appearance: white powder
Purity:98%min
TPPO:≤0.5%
Loss on drying:≤1% |
| 1030825-20-7 |
2-[(5-Bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene |
Anti-diabetic |
Canagliflozin hemihydrate Intermediates |
CAS NO: 1030825-20-7
Molecular formula: C18H14BrFS
Molecular weight: 361.27 |
Appearance: white powder
Purity:≥98.0% |
| 898566-17-1 |
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene |
Anti-diabetic |
Canagliflozin hemihydrate Intermediates |
CAS NO: 898566-17-1
Molecular formula: C18H14FIS
Molecular weight: 408.27 |
Appearance: Colorless to light-yellow crystalline solid powder
Purity: 98%min
Total impurity:≤2.0%
Loss on drying:≤1.0% |
| 27143-07-3 |
Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate |
Anti-coagulant |
Apixaban Intermediates |
CAS NO: 27143-07-3
Molecular formula: C11H13ClN2O3
Molecular weight: 256.69
Standard: Enterprise standard
Application: Apixaban Intermediates |
Appearance:Off-white to pale yellow powder
Identification:IR/HNMR
Loss on drying:≤0.5%
Purity:≥98.0% |
| 545445-44-1 |
5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone |
Anti-coagulant |
Apixaban Intermediates |
CAS NO: 545445-44-1
Molecular formula: C20H25N3O3
Molecular weight: 355.43
Standard: Enterprise standard
Application: Apixaban Intermediates |
Appearance:White to Off-white powder
Identification:IR/HNMR
Loss on drying:≤0.5%
Purity:≥98.0% |
| 503614-91-3 |
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester |
Anti-coagulant |
Apixaban Intermediates |
CAS NO: 503614-91-3
Molecular formula: C27H28N4O5
Molecular weight: 488.54
Standard: Enterprise standard
Application: Apixaban Intermediate |
Appearance"White to Off-white powder
Identification:IR/HNMR
Loss on drying:≤0.5%
Purity:≥98.0% |
| 97664-55-6 |
6-Benzylamino-1-(4'-phenylbutoxy)hexane |
Bronchodilators |
Salmeterol Intermediates |
CAS NO: 97664-55-6
Molecular formula: C23H33NO
Molecular weight: 339.51 |
Appearance: yellow oil
Purity: 98%min |
| 115787-50-3 |
5-Bromoacetyl-2-hydroxybenzaldehyde |
Bronchodilators |
Salmeterol Intermediates |
CAS NO: 115787-50-3
Molecular formula: C9H7BrO3
Molecular weight: 243.05 |
Appearance: light yellow crystalline powder
Purity: 98%min |
| 160969-03-9 |
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate |
Urinary |
Silodosin Intermediates |
CAS NO: 160969-03-9
Molecular formula: C11H13F3O5S
Molecular weight: 314.28
Standard: Enterprise standard
Application: Silodosin Intermediate |
Appearance:White crystalline powder
Identification:HPLC/IR
Loss on drying:≤1.0%
Purity:≥98.0% |
| 239463-85-5 |
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate |
Urinary |
Silodosin Intermediates |
CAS NO: 239463-85-5
Molecular formula: C22H25N3O2.C4H6O6
Molecular weight: 513.55
Standard: Enterprise standard
Application: Silodosin Intermediate |
Appearance:White to off-white crystalline powder
Identification:HPLC/IR
Loss on drying:≤1.0%
S-isomer:≤1.0%
Purity:≥98.0% |
| 1375180-30-5 |
1-[3-(Benzyloxy)propyl]-5-formylindoline-7-carbonitrile |
Urinary |
Silodosin Intermediates |
CAS NO: 1375180-30-5
Molecular formula: C22H24N2O2
Molecular weight: 320.38 |
Appearance: white crystalline powder
Purity: 98%min
|
| 4876-10-2 |
4-Bromomethyl-2(1H)-quinolinone |
Gastric mucosa protectives |
Rebamipide Intermediates |
CAS NO: 4876-10-2
Molecular formula: C10H8BrNO
Molecular weight: 238.08
Standard: Enterprise standard
Application: Rebamipide Intermediates |
Appearance:White or off-white crystalline powder
Identification:IR/HPLC
Loss on drying:≤0.4%
Residue on ignition:≤0.1%
Melting point:251.0~255.0℃
Purity:≥98.5% |
| 132210-24-3 |
2-Amino-3-(1,2-dihydro-2-oxoquinoline-4-yl)propanoic acid(H2O.HCL) |
Gastric mucosa protectives |
Rebamipide Intermediates |
CAS NO: 132210-24-3(1356182-56-3)
Molecular formula: C12H12N2O3
Molecular weight: 232.24
Standard: Enterprise standard
Application: Rebamipide Intermediates |
Appearance:White crystalline powder
Water:≤5.0%
Purity(HPLC):≥99.0%
Absorbance:≤0.03% |
| 5162-90-3(914769-50-9) |
2-Amino-3-(1,2-dihydro-2-oxoquinoline-4-yl)propanoic acid(2H2O.2HCL) |
Gastric mucosa protectives |
Rebamipide Intermediates |
CAS NO: 5162-90-3(914769-50-9)
Molecular formula: C10H8BrNO
Molecular weight: 238.0806
Standard: Enterprise standard
Application: Rebamipide Intermediates |
Appearance:White crystalline powder
Solubility:Soluble in N,N-Dimethylformamide,Slightly soluble in NaOH, very slightly in methanol and ethanol, practically insoluble in water and HCL solution
Water:10.0~13.0%
Acidity:20-23%
Purity:≥99.0% |
| 1068-90-2 |
Diethylacetamido Nalonate |
Gastric mucosa protectives |
Rebamipide Intermediates |
CAS NO: 1068-90-2
Molecular formula: C9H15NO5
Molecular weight: 217.22
Standard: Enterprise standard
Application: Rebamipide Intermediate |
Appearance:Colorless to light yellow liquid
Density:1.20~1.24g/ml
Purity:≥98.0%
Boiling point:192.0~194.0℃ |
| 33069-62-4 |
Paclitaxel |
Anti-cancer |
Taxane API |
CAS NO:33069-62-4
Molecular formula: C47H51NO14
Molecular weight: 853.91
Application: Natural anti-cancer plant extract
|
Appearance:White crystalline powder
Purity:≥98.0%
Quality:GMP,EP,USP |
| 114977-28-5 |
Docetaxel |
Anti-cancer |
Taxane API |
CAS NO:114977-28-5
Molecular formula: C43H53NO14
Molecular weight: 807.87922
Application: Natural anti-cancer plant extract |
Appearance:White crystalline powder
Purity:≥98.0%
Quality:EP,USP |
| 183133-96-2 |
Cabazitaxel |
Anti-cancer |
Taxane API |
CAS NO:183133-96-2 Molecular formula: C45H57NO14
Molecular weight: 835.93238
Application: Natural anti-cancer plant extract |
Appearance:White crystalline powder
Purity:≥98.0%
Quality:EP,USP
|
| 32981-86-5 |
10-Deacetyl Baccatin Ⅲ (10-DAB Ⅲ) |
Anti-cancer |
Taxane intermediates |
CAS NO:32981-86-5 Molecular formula: C29H36O10
Molecular weight: 544.59
Application: Natural anti-cancer plant extract |
Appearance:White crystalline powder
Purity:≥98.0%
Standard: EP,USP
Package:1kg/bag 25kg/drum |
| 114915-14-9 |
7,10-Ditroc-Docetaxel |
Anti-cancer |
Taxane intermediates |
CAS NO:114915-14-9 Molecular formula: C43H53NO14
Molecular weight: 807.885
Application: Natural anti-cancer plant extract |
Appearance:White crystalline powder
Purity:≥98.0%
Standard: EP,USP
Package:1kg/bag 25kg/drum |
| 183133-94-0 |
7,10-Dimethoxy-10-DAB Ⅲ |
Anti-cancer |
Taxane intermediates |
CAS NO:183133-94-0 Molecular formula: C31H40O10
Molecular weight: 572.6433
Application: Natural anti-cancer plant extract |
Appearance:White crystalline powder
Purity:≥98.0%
Standard: EP,USP
Package:1kg/bag 25kg/drum |
| 114915-17-2 |
7-Troc-Paclitaxel |
Anti-cancer |
Taxane intermediates |
CAS NO:114915-17-2 Molecular formula: C50H52Cl3NO16
Molecular weight: 1029.30398
Application: Natural anti-cancer plant extract |
Appearance:White crystalline powder
Purity:≥98.0%
Standard: EP,USP
Package:1kg/bag 25kg/drum |
| 158722-23-7 |
(N-1) Paclitaxel intermediate |
Anti-cancer |
Taxane intermediates |
CAS NO:158722-23-7 Molecular formula: C53H63NO13Si
Molecular weight: 950.15172
Application: Natural anti-cancer plant extract |
Appearance:White crystalline powder
Purity:≥98.0%
Standard: EP,USP
Package:1kg/bag 25kg/drum |
| 90332-63-1 |
7-Xylosyl-10-deacety Paclitaxel |
Anti-cancer |
Taxane intermediates |
CAS NO:90332-63-1 Molecular formula: C50H57NO17
Molecular weight: 943.99
Application: Natural anti-cancer plant extract |
Appearance:White crystalline powder
Purity:≥98.0%
Standard: EP,USP
Package:1kg/bag 25kg/drum |
| 95603-44-4 |
7,10-Ditroc-10-DABⅢ |
Anti-cancer |
Taxane intermediates |
CAS NO:95603-44-4 Molecular formula: C35H38Cl6O14
Molecular weight: 895.38582
Application: Natural anti-cancer plant extract |
Appearance:White crystalline powder
Purity:≥98.0%
Standard: EP,USP
Package:1kg/bag 25kg/drum |
